Top Clinical Research Stories


Comment & Analysis »

GlobalData Healthcare

Could Novartis’ longer-acting anti-VEGF Drug, RTH258, offset Lucentis’ loss to Eylea?

On June 20, Novartis announced that both of its head-to-head pivotal Phase III trials of RTH258 (brolucizumab), HAWK and HARRIER, met the primary endpoint of non-inferior efficacy...

Could Novartis’ longer-acting anti-VEGF Drug, RTH258, offset Lucentis’ loss to Eylea?
GlobalData Healthcare

NeuPSIG 2017: sodium channel blockers highlight a new approach to neuropathic pain

NeuPSIG 2017: sodium channel blockers highlight a new approach to neuropathic pain
GlobalData Healthcare

NeuPSIG 2017: three strategies for improving treatment options for neuropathic pain

NeuPSIG 2017: three strategies for improving treatment options for neuropathic pain
GlobalData Healthcare

EULAR 2017: Lupus community remains divided on outcome measures

EULAR 2017: Lupus community remains divided on outcome measures
GlobalData Healthcare

Fecal transplant-based treatment for C. difficile reaches phase III trials

Fecal transplant-based treatment for C. difficile reaches phase III trials

Company Releases »

Top Six Ways to Prevent Particle Sizing Failures with Laser Diffraction

Malvern Instruments
Top Six Ways to Prevent Particle Sizing Failures with Laser Diffraction

Contract Manufacturing Of Biopharmaceuticals

Biovian
Contract Manufacturing Of Biopharmaceuticals

Contract Development Services and Drug Delivery Systems

Softigel Contract Development Services and Drug Delivery Systems

Biopharmaceutical Laboratory Equipment and Integrated Bioprocess Services

Sartorius
Biopharmaceutical Laboratory Equipment and Integrated Bioprocess Services

Studying Biophysical Applications of Calorimetric Methods

Malvern Instruments Studying Biophysical Applications of Calorimetric Methods

Clinical Research Insights »

Companies »